Modeling the Impact of Prehospital Triage on a True-Life Drip and Ship Mechanical Thrombectomy Urban Patient Cohort.

Bypass model Drip and ship cohort Intravenous thrombolysis Large vessel occlusion Mothership cohort Stroke triage scale

Journal

Cerebrovascular diseases extra
ISSN: 1664-5456
Titre abrégé: Cerebrovasc Dis Extra
Pays: Switzerland
ID NLM: 101577885

Informations de publication

Date de publication:
2021
Historique:
received: 21 06 2021
accepted: 04 10 2021
pubmed: 26 11 2021
medline: 30 12 2021
entrez: 25 11 2021
Statut: ppublish

Résumé

The aim of the study was to model the effect of prehospital triage of emergent large vessel occlusion (ELVO) to endovascular capable center (ECC) on the timing of thrombectomy and intravenous (IV) thrombolysis using real-world data from a multihospital system. We selected a cohort of 77 consecutive stroke patients who were brought by emergency medical services (EMS) to a nonendovascular capable center and then transferred to an ECC for mechanical thrombectomy (MT) ("actual" drip and ship [DS] cohort). We created a hypothetical scenario (bypass model [BM]), modeling transfer of the patients directly to an ECC, based on patients' initial EMS pickup address and closest ECC. Using another cohort of 73 consecutive patients, who were brought directly to an ECC by EMS and underwent endovascular intervention, we calculated mean door-to-needle and door-to-arterial puncture (AP) times ("actual" mothership [MS] cohort). Timings in the actual MS cohort and the actual DS cohort were compared to timings from the BM cohort. Median first medical contact (FMC) to IV thrombolysis time was 87.5 min (interquartile range [IQR] = 38) for the DS versus 78.5 min (IQR = 8.96) for the BM cohort, with p = 0.1672. Median FMC to AP was 244 min (IQR = 97) versus 147 min (IQR = 8.96) (p < 0.001), and median FMC to TICI 2B+ time was 299 min (IQR = 108.5) versus 197 min (IQR = 8.96) (p < 0.001) for the DS versus BM cohort, respectively. Modeled EMS prehospital triage of ELVO patients' results in shorter MT times without a change in thrombolysis times. As triage tools increase in sensitivity and specificity, EMS triage protocols stand to improve patient outcomes.

Identifiants

pubmed: 34823243
pii: 000520078
doi: 10.1159/000520078
pmc: PMC8740215
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-144

Informations de copyright

© 2021 The Author(s). Published by S. Karger AG, Basel.

Références

J Neurointerv Surg. 2019 Jan;11(1):14-19
pubmed: 30297541
JAMA Neurol. 2020 Jun 1;77(6):691-699
pubmed: 32250423
Stroke. 2018 Oct;49(10):2532-2535
pubmed: 30355100
Neurol Res Pract. 2021 Jun 1;3(1):31
pubmed: 34059132
J Neurointerv Surg. 2020 Mar;12(3):233-239
pubmed: 31484698
Stroke. 2014 Jan;45(1):87-91
pubmed: 24281224
J Stroke Cerebrovasc Dis. 2015 Sep;24(9):2161-6
pubmed: 26159643
Stroke. 2017 Dec;48(12):3295-3300
pubmed: 29146873
Stroke. 2018 Apr;49(4):945-951
pubmed: 29540611
Stroke. 2015 Aug;46(8):2156-61
pubmed: 26106117
Stroke. 2021 Aug;52(9):e527-e530
pubmed: 34348472
J Neurointerv Surg. 2017 Jul;9(7):631-635
pubmed: 27342763
JAMA Neurol. 2018 Dec 1;75(12):1477-1486
pubmed: 30193366
Prehosp Emerg Care. 2021 Jan-Feb;25(1):67-75
pubmed: 32017644
Stroke Vasc Neurol. 2019 Nov 28;5(1):80-85
pubmed: 32411412
Int J Stroke. 2019 Jan;14(1):12-22
pubmed: 30303811
Prehosp Emerg Care. 2019 Sep-Oct;23(5):612-618
pubmed: 30668202
J Neurointerv Surg. 2020 Nov;12(11):1058-1063
pubmed: 32385089
J Neurointerv Surg. 2020 Apr;12(4):356-362
pubmed: 31444290
Stroke. 2017 Mar;48(3):791-794
pubmed: 28100764
JAMA Neurol. 2017 Jul 1;74(7):793-800
pubmed: 28492918
Stroke. 2021 Apr;52(4):1441-1445
pubmed: 33641383
Circulation. 2017 Dec 12;136(24):2311-2321
pubmed: 28943516
JAMA Neurol. 2017 May 1;74(5):549-556
pubmed: 28319240
JAMA. 2020 Jun 2;323(21):2170-2184
pubmed: 32484532
Lancet Neurol. 2017 Mar;16(3):227-237
pubmed: 28229894
Stroke. 2020 Dec;51(12):3495-3503
pubmed: 33131426
Cochrane Database Syst Rev. 2019 Apr 09;4:CD011427
pubmed: 30964558
Stroke. 2017 Jan;48(1):233-238
pubmed: 27899757

Auteurs

Stavros Matsoukas (S)

Department of Neurosurgery, The Mount Sinai Hospital, New York, New York, USA, stavros.matsoukas@mountsinai.org.

Brian Giovanni (B)

Department of Neurosurgery, The Mount Sinai Hospital, New York, New York, USA.

Liorah Rubinstein (L)

Department of Neurosurgery, The Mount Sinai Hospital, New York, New York, USA.

Shahram Majidi (S)

Department of Neurosurgery, The Mount Sinai Hospital, New York, New York, USA.

Laura K Stein (LK)

Department of Neurology, The Mount Sinai Hospital, New York, New York, USA.

Johanna T Fifi (JT)

Department of Neurosurgery, The Mount Sinai Hospital, New York, New York, USA.
Department of Neurology, The Mount Sinai Hospital, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH